Prothena Net Income From Continuing Ops from 2010 to 2026
| PRTA Stock | USD 8.81 0.25 2.76% |
Net Loss | First Reported 2010-12-31 | Previous Quarter -125.8 M | Current Value -36.5 M | Quarterly Volatility 34 M |
Check Prothena Plc financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Prothena Plc's main balance sheet or income statement drivers, such as Depreciation And Amortization of 975.6 K, Interest Expense of 8.1 M or Selling General Administrative of 81.1 M, as well as many indicators such as Price To Sales Ratio of 6.02, Dividend Yield of 0.0 or PTB Ratio of 1.67. Prothena financial statements analysis is a perfect complement when working with Prothena Plc Valuation or Volatility modules.
Prothena | Net Income From Continuing Ops | Build AI portfolio with Prothena Stock |
Analyzing Prothena Plc's Net Income From Continuing Ops over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income From Continuing Ops has evolved provides context for assessing Prothena Plc's current valuation and future prospects.
Latest Prothena Plc's Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of Prothena plc over the last few years. It is Prothena Plc's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Prothena Plc's overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
Prothena Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | (85,560,644) | |
| Geometric Mean | 76,095,798 | |
| Coefficient Of Variation | (72.03) | |
| Mean Deviation | 49,651,430 | |
| Median | (110,079,000) | |
| Standard Deviation | 61,627,010 | |
| Sample Variance | 3797.9T | |
| Range | 227.1M | |
| R-Value | (0.39) | |
| Mean Square Error | 3447.9T | |
| R-Squared | 0.15 | |
| Significance | 0.13 | |
| Slope | (4,708,989) | |
| Total Sum of Squares | 60766.2T |
Prothena Net Income From Continuing Ops History
About Prothena Plc Financial Statements
Prothena Plc stakeholders use historical fundamental indicators, such as Prothena Plc's Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although Prothena Plc investors may analyze each financial statement separately, they are all interrelated. For example, changes in Prothena Plc's assets and liabilities are reflected in the revenues and expenses on Prothena Plc's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Prothena plc. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Loss | -110.1 M | -115.6 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Prothena plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Prothena Plc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Prothena Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Prothena Plc Stock:Check out the analysis of Prothena Plc Correlation against competitors. For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Prothena Plc. Anticipated expansion of Prothena directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Prothena Plc assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (5.20) | Revenue Per Share | Quarterly Revenue Growth 1.49 | Return On Assets | Return On Equity |
The market value of Prothena plc is measured differently than its book value, which is the value of Prothena that is recorded on the company's balance sheet. Investors also form their own opinion of Prothena Plc's value that differs from its market value or its book value, called intrinsic value, which is Prothena Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Prothena Plc's market value can be influenced by many factors that don't directly affect Prothena Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Prothena Plc's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Prothena Plc should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Prothena Plc's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.